Insights

Strategic partnerships Replicate Bioscience is actively pursuing collaborations with major pharma and biotech players (Novo Nordisk, Instituto Butantan) and has Gates Foundation funding, signaling strong appetite for commercial partnerships and funded programs in srRNA vaccines and therapeutics.

Healthcare impact The srRNA platform targets infectious disease, immuno-oncology, autoimmune diseases, and cardiometabolic conditions, indicating cross‑segment potential for partnerships with vaccines, oncology, and metabolic disease teams seeking next‑gen RNA delivery technologies.

Funding momentum Recent grants and a multi‑year collaboration backdrop, including a $3M Gates Foundation grant and ongoing industry partnerships, suggest a growing budget runway and potential for co‑development funding, grants consulting, and milestone‑driven deals.

Executive alignment Appointment of a Chief Business Officer and ongoing business development activities imply a strengthened go‑to‑market strategy, making the company more approachable for licensing, collaboration, and strategic投资 discussions.

Commercial readiness With demonstrated revenue and a relatively lean team, there is an opportunity to offer CRO/CMO services, process development, and Vector/srRNA optimization collaborations to accelerate partner programs and de‑risk early clinical timelines.

Replicate Bioscience, Inc. Tech Stack

Replicate Bioscience, Inc. uses 8 technology products and services including WordPress, Microsoft 365, Google Cloud, and more. Explore Replicate Bioscience, Inc.'s tech stack below.

WordPress

Content Management System

Microsoft 365

Google Cloud

Infrastructure As A Service

Polyfill

Javascript Libraries

WordPress Block Editor

Page Builders

WP Engine

Platform As A Service

HTTP/3

Web & Portal Technology

Sitelinks Search Box

Web Tools And Plugins

Replicate Bioscience, Inc. Email Formats	Example	Percentage
FLast@replicatebioscience.com	JDoe@replicatebioscience.com	100%

Replicate Bioscience, Inc. Email Formats

Example

Percentage

FLast@replicatebioscience.com

JDoe@replicatebioscience.com

100%

Frequently Asked Questions

What is Replicate Bioscience, Inc.'s official website and social media links?

Replicate Bioscience, Inc.'s official website is replicatebioscience.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Replicate Bioscience, Inc. generate?

As of October 2026, Replicate Bioscience, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Replicate Bioscience, Inc.'s SIC code and NAICS code?

Replicate Bioscience, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Replicate Bioscience, Inc. have currently?

As of October 2026, Replicate Bioscience, Inc. has approximately 23 employees across 1 continents, including North America. Key team members include Scientific Director | Head Of Technology: S. M. Explore Replicate Bioscience, Inc.'s employee directory with LeadIQ.

What industry does Replicate Bioscience, Inc. belong to?

Replicate Bioscience, Inc. operates in the Biotechnology Research industry.

What technology does Replicate Bioscience, Inc. use?

Replicate Bioscience, Inc.'s tech stack includes WordPress, Microsoft 365, Google Cloud, Polyfill, WordPress Block Editor, WP Engine, HTTP/3 and Sitelinks Search Box.

What is Replicate Bioscience, Inc.'s email format?

Replicate Bioscience, Inc.'s email format typically follows the pattern of FLast@replicatebioscience.com. Find more Replicate Bioscience, Inc. email formats with LeadIQ.

How much funding has Replicate Bioscience, Inc. raised to date?

As of October 2026, Replicate Bioscience, Inc. has raised $53M in funding. The last funding round occurred on Jan 08, 2026 for $40M.

When was Replicate Bioscience, Inc. founded?

Replicate Bioscience, Inc. was founded in 2020.

Replicate Bioscience, Inc.

Q: How many employees does Replicate Bioscience, Inc. have currently?

Replicate Bioscience, Inc. has approximately 23 employees.

Q: What technology does Replicate Bioscience, Inc. use?

Replicate Bioscience, Inc.'s tech stack includes RSS, oEmbed, GoDaddy Website Builder, Nginx, HTTP/3.

Q: What is Replicate Bioscience, Inc.'s NAICS code?

Replicate Bioscience, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States11-50 Employees

Replicate Bioscience, Inc. operates in the biotechnology research space, pursuing RNA-based therapeutics through self-replicating RNA technology. Its srRNA constructs pair a replication-capable genetic payload with RNA that encodes a therapeutic protein, enabling controlled production of the target protein inside cells. The company maintains a library of synthetic srRNA vectors chosen to drive strong and sustained protein expression, with performance described as markedly better than traditional linear mRNA. These capabilities position Replicate to advance treatments in oncology, infectious disease, and autoimmunity, among other areas.

Headquartered in San Diego, California, the company is described as a small-to-mid-sized biotechnology research firm with a focused team of srRNA experts. In 2025 and 2026, Replicate formed a multi-year collaboration with Novo Nordisk to develop srRNA-based therapies for obesity, Type 2 diabetes, and related cardiometabolic diseases, reflecting its position within the industry as a partner for large pharmaceutical developers.

Insights

Similar companies to Replicate Bioscience, Inc.